Elevance Health outperforms competitors by managing Medicare Advantage costs effectively and driving robust growth in its Carelon segment, bolstering its 2025 outlook and earning a Strong Buy rating with growth potential.

Pharmaceutical companies increased consumer-directed drug advertising by nearly 30% in early 2025, leveraging tax deductions that affect prescription drug prices, according to AHIP and CSRxP analyses.

CMS fines three PACE organizations totaling $142,788 for failure to meet essential service and documentation requirements, highlighting compliance challenges in managed care programs.

Explore the impact of Medicare Administrative Contractors on coverage decisions for advanced wound care therapies and the potential of AI-driven reforms to improve patient access and reduce costs.

Federal court permits whistleblower's False Claims Act allegations against UnitedHealthcare for improper Medicare Advantage billing to move forward, highlighting legal risks in healthcare billing compliance.

Medicare does not recognize individual health plans as qualifying employer coverage for delaying Part B enrollment. Self-employed individuals must enroll timely to avoid penalties.

CMS's 2026 Final Rule implements the Medicare Drug Price Negotiation Program with the Medicare Transaction Facilitator, affecting Part D drug pricing and pharmacy reimbursement processes.

Congressional budget cuts proposed by House Republicans raise concerns about potential impacts on Medicare, Medicaid, and Veterans Affairs funding. Key debates focus on program efficiency versus benefit reductions.

Learn how proposed $880 billion Medicaid cuts could affect Iowa's Medicaid program, healthcare access, and economic stability, including job losses and state revenue decline.

Dr. Mehmet Oz confirmed as CMS Administrator with mandate to protect and grow Medicare Advantage, improving care and reducing costs for seniors.